[go: up one dir, main page]

WO2003086267A3 - Systeme capsulaire a plusieurs compartiments et plusieurs phases - Google Patents

Systeme capsulaire a plusieurs compartiments et plusieurs phases Download PDF

Info

Publication number
WO2003086267A3
WO2003086267A3 PCT/US2003/010816 US0310816W WO03086267A3 WO 2003086267 A3 WO2003086267 A3 WO 2003086267A3 US 0310816 W US0310816 W US 0310816W WO 03086267 A3 WO03086267 A3 WO 03086267A3
Authority
WO
WIPO (PCT)
Prior art keywords
ingredient
receiving chamber
phase
physical state
capsular system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/010816
Other languages
English (en)
Other versions
WO2003086267A2 (fr
WO2003086267B1 (fr
Inventor
Fred H Miller
Lance R Ausec
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/368,951 external-priority patent/US20030194428A1/en
Priority to JP2003583294A priority Critical patent/JP2005528383A/ja
Priority to NZ536267A priority patent/NZ536267A/en
Priority to EP03717010A priority patent/EP1499303A4/fr
Priority to CA2481486A priority patent/CA2481486C/fr
Priority to AU2003220689A priority patent/AU2003220689A1/en
Application filed by Individual filed Critical Individual
Publication of WO2003086267A2 publication Critical patent/WO2003086267A2/fr
Publication of WO2003086267A3 publication Critical patent/WO2003086267A3/fr
Priority to US10/804,576 priority patent/US7670612B2/en
Publication of WO2003086267B1 publication Critical patent/WO2003086267B1/fr
Anticipated expiration legal-status Critical
Priority to US12/689,669 priority patent/US8361497B2/en
Priority to US13/746,743 priority patent/US20130136791A1/en
Priority to US14/036,521 priority patent/US9241911B2/en
Priority to US15/005,508 priority patent/US9539216B2/en
Ceased legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C39/00—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor
    • B29C39/02—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor for making articles of definite length, i.e. discrete articles
    • B29C39/10—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor for making articles of definite length, i.e. discrete articles incorporating preformed parts or layers, e.g. casting around inserts or for coating articles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/0058—Liquid or visquous
    • B29K2105/0061—Gel or sol

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne une capsule à plusieurs compartiments comprenant une première chambre réceptrice renfermant au moins un ingrédient présentant un premier état physique, lequel ingrédient est sélectionné dans un groupe renfermant un nutraceutique, une vitamine, un complément alimentaire et un minéral ; ainsi qu'une seconde chambre réceptrice renfermant au moins un ingrédient présentant un second état physique, lequel ingrédient est sélectionné dans le groupe renfermant un nutraceutique, une vitamine, un complément alimentaire et un minéral. Selon cette invention, le premier état physique de l'ingrédient contenu dans la première chambre réceptrice est différent du second état physique de l'ingrédient contenu dans la seconde chambre réceptrice, lequel ingrédient contenu dans la première chambre réceptrice est différent de celui contenu dans la seconde chambre réceptrice.
PCT/US2003/010816 2002-04-10 2003-04-09 Systeme capsulaire a plusieurs compartiments et plusieurs phases Ceased WO2003086267A2 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP2003583294A JP2005528383A (ja) 2002-04-10 2003-04-09 多重相・複数コンパートメントカプセルシステム
NZ536267A NZ536267A (en) 2002-04-10 2003-04-09 Multi-phase, multi-compartment and multi-ingredient capsular system
EP03717010A EP1499303A4 (fr) 2002-04-10 2003-04-09 Systeme capsulaire a plusieurs compartiments et plusieurs phases
CA2481486A CA2481486C (fr) 2002-04-10 2003-04-09 Systeme capsulaire a plusieurs compartiments et plusieurs phases
AU2003220689A AU2003220689A1 (en) 2002-04-10 2003-04-09 Multi-phase, multi-compartment capsular system
US10/804,576 US7670612B2 (en) 2002-04-10 2004-03-19 Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
US12/689,669 US8361497B2 (en) 2002-04-10 2010-01-19 Multi-phase, multi-compartment, capsular delivery apparatus and methods for using the same
US13/746,743 US20130136791A1 (en) 2002-04-10 2013-01-22 Multi-phase, mult-compartment capsular delivery apparatus and methods for using same
US14/036,521 US9241911B2 (en) 2002-04-10 2013-09-25 Multi-phase, multi-compartment, capsular delivery apparatus and methods for using same
US15/005,508 US9539216B2 (en) 2002-04-10 2016-01-25 Multi-phase, multi-compartment, capsular delivery apparatus and methods for using same

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US37144802P 2002-04-10 2002-04-10
US60/371,448 2002-04-10
US10/368,951 US20030194428A1 (en) 2002-04-10 2003-02-18 Process for encapsulating multi-phase, multi-compartment capsules
US10/369,247 2003-02-18
US10/369,427 2003-02-18
US10/369,247 US20030194430A1 (en) 2002-04-10 2003-02-18 Process for encapsulating multi-phase, multi-compartment capsules for therapeutic compositions
US10/369,427 US20030194431A1 (en) 2002-04-10 2003-02-18 Multi-phase,multi-compartment capsular delivery apparatus and methods for using same
US10/369,244 US20030194429A1 (en) 2002-04-10 2003-02-18 Multi-phase, multi-compartment capsular delivery apparatus for therapeutic compositions and methods for using same
US10/368,951 2003-02-18
US10/369,244 2003-02-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US37144802P Substitution 2002-04-10 2002-04-10

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/804,576 Continuation-In-Part US7670612B2 (en) 2002-04-10 2004-03-19 Multi-phase, multi-compartment capsular delivery apparatus and methods for using same

Publications (3)

Publication Number Publication Date
WO2003086267A2 WO2003086267A2 (fr) 2003-10-23
WO2003086267A3 true WO2003086267A3 (fr) 2003-12-18
WO2003086267B1 WO2003086267B1 (fr) 2004-04-29

Family

ID=29255682

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/010816 Ceased WO2003086267A2 (fr) 2002-04-10 2003-04-09 Systeme capsulaire a plusieurs compartiments et plusieurs phases

Country Status (6)

Country Link
EP (1) EP1499303A4 (fr)
JP (2) JP2005528383A (fr)
AU (3) AU2003220689A1 (fr)
CA (1) CA2481486C (fr)
NZ (1) NZ536267A (fr)
WO (1) WO2003086267A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8383579B2 (en) 2004-11-19 2013-02-26 GlaxoSmithKline, LLC Method for customized dispensing of variable dose drug combination products for individualizing of therapies

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0012869A (pt) 1999-07-30 2002-05-21 Smithkline Beecham Plc Forma de dosagem farmacêutica de componentes múltiplos
US7790762B2 (en) 2002-10-31 2010-09-07 National Jewish Health Compounds and methods for thiol-containing compound efflux and cancer treatment
US20040087527A1 (en) * 2002-10-31 2004-05-06 Day Brian J. Methods for treatment of thiol-containing compound deficient conditions
DE10359792A1 (de) * 2003-12-19 2005-07-21 Bayer Technology Services Gmbh Mehrphasige Wirkstoffformulierung
WO2005099761A1 (fr) * 2004-04-07 2005-10-27 Resveratrol Partners, Llc Supplement dietetique et procede de traitement de ce dernier
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
JP2006321730A (ja) * 2005-05-17 2006-11-30 Maruzen Pharmaceut Co Ltd 抗酸化剤及び抗老化剤、並びに皮膚化粧料及び飲食物
US7781572B2 (en) * 2005-10-05 2010-08-24 Nse Products, Inc. Nanosized carotenoid cyclodextrin complexes
SI3095447T1 (sl) 2006-02-03 2022-02-28 Opko Renal, Llc Zdravljenje pomanjkanja vitamina D s 25-hidroksivitaminom D2 in 25-hidroksivitaminom D3
ES2670029T3 (es) 2006-06-21 2018-05-29 Opko Ireland Global Holdings, Ltd. Terapia usando agente de repleción de la vitamina D y agente de reemplazo de la hormona de la vitamina D
AU2007278986B2 (en) 2006-07-25 2010-09-16 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with PPI
US20130115320A1 (en) 2007-03-30 2013-05-09 Dynova Laboratories, Inc. Therapeutic agent for intranasal administration and method of making and using same
DK2148661T3 (da) 2007-04-25 2013-03-25 Cytochroma Inc Orale præparater med kontrolleret afgivelse omfattende vitamin D-forbindelse og voksagtig bærer
EP2148684B1 (fr) 2007-04-25 2013-01-16 Cytochroma Inc. Procédé de traitement d'une insuffisance et d'une carence en vitamine d
US7867524B2 (en) 2007-10-05 2011-01-11 David Rowland Energizing formulation
WO2010122499A2 (fr) * 2009-04-20 2010-10-28 Ecole Polytechnique Federale De Lausanne (Epfl) Récipients assemblés dans un fluide et production correspondante
KR101143997B1 (ko) * 2010-03-04 2012-05-09 한미사이언스 주식회사 유산균 제제 및 5-ｈｔ4 수용체 효능제를 함유하는 경구 투여용 복합 제제 및 이의 제조방법
CA2797537C (fr) 2010-03-29 2021-11-23 Cytochroma Inc. Utilisation du compose de 25-hydroxyvitamine d pour la reduction des niveaux de la parathyroide
CA3065589C (fr) 2010-06-03 2022-04-26 Catalent Ontario Limited Capsules multiphases de gel mou, appareil et procede pour celles-ci
EP2595597B1 (fr) * 2010-07-19 2017-09-13 Procaps S.A. Dispositif et procédé pour encapsuler des capsules ou d'autres formes galéniques solides dans des capsules
US20120082719A1 (en) * 2010-10-05 2012-04-05 Sam Poon Ang Compositions For Treating Chronic Viral Infections
CN102335095A (zh) * 2011-10-12 2012-02-01 李思思 d-柠檬烯硬胶囊的一种制造技术
US10130760B2 (en) * 2013-03-15 2018-11-20 Incube Labs, Llc Multi-stage biodegradable drug delivery platform
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
WO2016020508A2 (fr) * 2014-08-07 2016-02-11 Opko Ireland Global Holdings Ltd. Thérapie d'appoint avec de la 25-hydroxyvitamine d
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US9468659B2 (en) 2014-11-06 2016-10-18 NWO Stem Cure, LLC Nutraceutical supplement with Lactobacillus rhamnosus
US9980993B2 (en) 2014-11-06 2018-05-29 NWO Stem Cure, LLC Nutraceutical supplement with Lactobacillus rhamnosus
KR20230054752A (ko) 2016-03-28 2023-04-25 옵코 아일랜드 글로벌 홀딩스 리미티드 비타민 d 치료 방법
CN108753621A (zh) * 2018-05-30 2018-11-06 昆明理工大学 一种基于糖蜜废醪液提高单针藻油脂积累的方法
JP7229012B2 (ja) * 2018-12-25 2023-02-27 小林製薬株式会社 内服用医薬組成物
IT201900025063A1 (it) * 2019-12-20 2021-06-20 Idi Integratori Dietetici Italiani S R L Composizioni gastroresistenti comprendi inositolo e/o estratto di gymnema sylvestre, loro composizioni farmaceutiche e nutraceutiche e loro uso
US20210315930A1 (en) * 2020-04-14 2021-10-14 David A. Cuddeback Nutraceutical composition for multimodal prophylaxis against and treatment of viral and bacterial infection and inflammation
KR20230031287A (ko) * 2021-08-26 2023-03-07 컨템포러리 엠퍼렉스 테크놀로지 씨오., 리미티드 액체 백, 전지 셀, 전지 및 전기 장치
CN118948861B (zh) * 2024-10-15 2024-12-24 山东和美欣动物药业有限公司 一种鸡源胆汁提取物牛磺鹅去氧胆酸组合物及其在制备提升芦丁鸡产蛋期抗应激药物中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185740A (en) * 1978-08-02 1980-01-29 Johnson & Johnson Disposable capsules
US4940499A (en) * 1989-05-23 1990-07-10 Warner-Lambert Company Method and apparatus for sealing capsules containing medicaments

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2729068A1 (de) * 1977-06-28 1979-01-11 Rainer Dr Med Liedtke Verfahren zur freisetzungssteuerung von arzneimitteln aus kapseln
CH661878A5 (de) * 1983-11-04 1987-08-31 Warner Lambert Co Kapsel-dosierungsformen.
JPS6342094Y2 (fr) * 1985-07-02 1988-11-04
DE3543154A1 (de) * 1985-12-06 1987-06-11 Boehringer Ingelheim Kg Teilbare kapsel
ATE113471T1 (de) * 1989-08-17 1994-11-15 Cortecs Ltd Arzneiformulierungen.
US5501857A (en) * 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
JPH06316517A (ja) * 1993-02-22 1994-11-15 Grelan Pharmaceut Co Ltd 放出制御製剤
JP2000239159A (ja) * 1999-02-19 2000-09-05 Nitto Yakuhin Kogyo Kk カプセル剤およびその製造方法
AP1806A (en) * 1999-04-13 2007-12-14 Beecham Pharmaceuticals Pte Ltd The use of a high dosage regimen of amoxycillin and potassium chavulate for the treatment of bacterial infections.
ES2222253T3 (es) * 1999-11-17 2005-02-01 Reckitt Benckiser (Uk) Limited Recipientes solubles en agua moldeados por inyeccion.
US6372252B1 (en) * 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
WO2002007710A2 (fr) * 2000-07-20 2002-01-31 Mw Encap Limited Dispositif de delivrance

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185740A (en) * 1978-08-02 1980-01-29 Johnson & Johnson Disposable capsules
US4940499A (en) * 1989-05-23 1990-07-10 Warner-Lambert Company Method and apparatus for sealing capsules containing medicaments

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1499303A4 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8383579B2 (en) 2004-11-19 2013-02-26 GlaxoSmithKline, LLC Method for customized dispensing of variable dose drug combination products for individualizing of therapies

Also Published As

Publication number Publication date
AU2009202495A1 (en) 2009-07-16
AU2011202164A1 (en) 2011-06-02
NZ536267A (en) 2007-06-29
AU2009202495B2 (en) 2011-02-10
WO2003086267A2 (fr) 2003-10-23
CA2481486C (fr) 2012-06-12
WO2003086267B1 (fr) 2004-04-29
EP1499303A2 (fr) 2005-01-26
JP2005528383A (ja) 2005-09-22
CA2481486A1 (fr) 2003-10-23
EP1499303A4 (fr) 2007-07-25
JP2011068664A (ja) 2011-04-07
AU2003220689A1 (en) 2003-10-27

Similar Documents

Publication Publication Date Title
WO2003086267A3 (fr) Systeme capsulaire a plusieurs compartiments et plusieurs phases
WO2005034650A8 (fr) Complement nutritionnel d'amaigrissement
EP1293503A4 (fr) Derives de triazole
AU1030501A (en) Microcapsules for stabilizing cosmetic, pharmaceutical or food products
EP2279729A3 (fr) Préparations à libération controllée
EP1072254A4 (fr) Compositions alimentaires, compositions orales et compositions medicinales servant a prevenir ou traiter la parodontose et procede de prevention ou de traitement de la parodontose
AU2001244614A1 (en) Oily compositions containing highly fat-soluble drugs
AU4683800A (en) Dietary supplement
NO20013242D0 (no) Benzopyraner og benzoksepiner, farmasöytiske preparater som omfatter dem, og fremgangsmåte for fremstilling av dem
AUPR684801A0 (en) Supplement therapy
AU2001283255A1 (en) Products comprising corn oil and corn meal obtained from high oil corn
AU3335300A (en) Ingredients for expanded foods
WO2002043736A1 (fr) Aliments et boissons embellissants et preparations perorales embellissantes
WO2001010816A3 (fr) Derives de 2-dialkylaminoalkylbiphenyle
AU2003223989A1 (en) System for orally administering active substances, vitamins and/or foodstuffs
AU2002351764A1 (en) Flavonoid compounds and their pharmaceutical uses
WO2004073033A3 (fr) Systeme d'encapsulation de matiere
EE05491B1 (et) Leeliselist sfingomelinaasi sisaldav kompositsioon kasutamiseks dieteetilise valmistise, toidulisandi v?i farmatseutilise tootena
AU2002241408A1 (en) Modular system of dietary supplement compositions comprising vitamins
AU1406601A (en) Food product comprising encapsulated drugs
AU2002361083A1 (en) Edible capsules
AU2002350386A1 (en) Orally administered pharmaceutical preparation comprising liposomically encapsulated paclitaxel
AU2003221417A1 (en) Packaged oil-in-water type emulsion food and process for producing the same
AU2003263897A1 (en) Medicinal product packaging
AU7953800A (en) Drugs, drinks or foods

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 10804576

Country of ref document: US

B Later publication of amended claims

Effective date: 20031217

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2481486

Country of ref document: CA

Ref document number: 2003583294

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2003220689

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 536267

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2003717010

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003717010

Country of ref document: EP